DeepMatter

Activities: Manufacturing Research & Development

Trending Articles

  1. Johnson & Johnson to bolster neuroscience portfolio with $14.6bn Intra-Cellular Therapies acquisition Through this potential acquisition, Johnson & Johnson will add schizophrenia and bipolar drug Caplyta to its portfolio, as well as a range of clinical candidates designed to...
  2. Lonza and Iconovo collaborate to develop intranasal biologic for obesity The two will aim to create an effective and stable inhaled formulation that can be used to treat obesity without the need for frequent injections
  3. Teva Pharmaceuticals, Klinge Pharma and Formycon join forces to commercialise Eylea biosimilar FYB203, which will be marketed under the name AHZANTIVE®3 if approved by the EMA, will be commercialised by Teva Pharmaceuticals in the majority of Europe and Israel
  4. You need to be a subscriber to read this article.
    Click here to find out more.
    Revolutionising drug delivery and advancing sustainability Capsule innovation and 3D printing will transform pharma for a future of precision and ethical solutions
  5. MM Pharma showcases its secondary packaging solutions at Pharmapack Europe 2025 Visitors to booth J85 can chat with technical experts about pharmaceutical packaging challenges and requirements, as well as how MM Pharma can help with their secondary...

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

Related Content

Manufacturing

Cloud based smart chemistry platform

This single platform allows reaction data to be compiled from multiple data sources to provide a cleansed, harmonised, and categorised repository
Research & Development

DeepMatter provides software platform for University of Cambridge

DigitalGlassware is a cloud-based platform designed to allow scientists to bring together digitised synthesis protocols
Finance

DeepMatter appointments Non-Executive Director

The company will seek to leverage his knowledge to further develop its data platforms and ensure they meet the needs of the pharmaceutical industry
Research & Development

DeepMatter collaborates with universities on manufacturing

The company will provide its DigitalGlassware software, a cloud-based platform that allows chemists to share data in real-time and digitally enable scale-up of advanced nanoparticle products
Manufacturing

AstraZeneca chooses DeepMatter for optimisation of compound synthesis

DeepMatter has joined forces with AstraZeneca to improve productivity using digital equipment enabled with machine learning and AI
Subscribe now